AgeX Therapeutics

Aging, Redefined

Our Mission

AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population.

“The prolongation of life is after all the aim and goal of the physician’s endeavors.”

 

– I. L. Nascher

“The prolongation of life is after all the aim and goal of the physician’s endeavors.”

 

– I. L. Nascher

A Subsidiary of: